Global investment firm TPG has entered into a binding agreement to acquire a 35% stake in SCHOTT Poonawalla Pvt Ltd, a ...

Global investment firm TPG has signed a legally binding agreement to purchase a 35% ownership in SCHOTT Poonawalla, the joint venture between Serum Institute of India (SII) and Germany-based SCHOTT ...

The momentum in London-New Delhi ties is backed by business enthusiasm. With a free trade agreement (FTA) in place, let’s ...

Karan Johar made headlines when he sold a 50 percent stake of his production company, Dharma Productions, to Serum Institute ...

TPG, a leading global alternative asset management firm will acquire 35% stake in SCHOTT Poonawalla from Serum Institute of India (SII) SII will retain a minority stake in the company, with SCHOTT ...

TPG will acquire a 35% stake in SCHOTT Poonawalla from the Serum Institute of India. This joint venture with SCHOTT Pharma is ...

TPG Growth, TPG’s middle market and growth equity platform, is funding the investment, along with Novo Holdings as a ...

TPG, a global alternative asset management firm, has entered into a binding agreement to acquire a 35% stake in SCHOTT ...

TPG is acquiring a 35% stake in SCHOTT Poonawalla, a joint venture of SCHOTT Pharma and Serum Institute of India. The deal is ...

Global alternative asset firm TPG has acquired a 35% stake in SCHOTT Poonawalla, a joint venture between SCHOTT Pharma and ...

TPG has entered into a binding agreement to acquire 35% stake in Schott Poonawalla from Serum Institute of India (SII), said ...

The transaction, funded through TPG Growth and co-investor Novo Holdings, is expected to close in the first half of 2025.